Frequently Asked Questions
Our FAQ page offers essential details about Chirayu Super Speciality Hospital's services, treatments, and appointment booking. Find answers to common questions about our specialized medical care, diagnostic tests, and treatment options. This resource ensures a smooth, informed experience when accessing our comprehensive healthcare services.
1. PT / INR
The target INR range for patients on warfarin therapy varies depending on their condition but is typically between 2.0 and 3.0.
Frequency of testing depends on individual patient needs, but initially, it may be done weekly or bi-weekly until stable, then less frequently thereafter.
Yes, the PT / INR Test can help diagnose various clotting disorders, including those related to liver disease or genetic clotting factor deficiencies.
Medications, dietary changes, liver function, and underlying health conditions can all influence PT / INR results.
Yes, the PT / INR Test is a safe and standard diagnostic procedure used worldwide to monitor blood clotting ability and adjust anticoagulant therapy.
2. What are the risks associated with cystoscopy surgery?
Risks include mild discomfort, potential infection, and, rarely, injury to the urethra or bladder.
3. HEPATITIS B CORE
The Hepatitis B Core Antibody Test detects antibodies against the core antigen of Hepatitis B virus, indicating past or current infection.
The test is used to diagnose Hepatitis B infection, assess immune response, and guide further testing.
No special preparation is needed. You can eat and drink normally. Inform your healthcare provider about any medications or recent health issues.
Results are typically available within 1 to 2 days after the test.
A positive result indicates past or current exposure to Hepatitis B virus. It may require further testing to determine the infection stage and appropriate management.